Patent Office To Drop Some Proposed Revisions To Patent Challenge Proceedings, Vidal Tells Congress

Not all PTAB changes floated in advanced notice of proposed rulemaking will be pursued, and the rule may be split into two, USPTO Director Vidal testifies. PhRMA, BIO, AAM criticize the proposals.

Katherine Vidal
USPTO Director Katherine Vidal testifies at congressional hearing • Source: Screenshot of Senate Judiciary IP subcommittee hearing

The US Patent and Trademark Office will not be pursuing all the proposed changes to Patent Trial and Appeal Board proceedings that are included in its recent advanced notice of proposed rulemaking.

Testifying at the 26 July oversight hearing of the Senate Judiciary Committee’s Intellectual Property Subcommittee, USPTO Director Katherine Vidal said...

More from Legal & IP

More from Pink Sheet